Proteomic Discovery and Verification of Serum Amyloid a as a Predictor Marker of Patients at Risk of Post-Stroke Infection: A Pilot Study
Clinical Proteomics - United Kingdom
doi 10.1186/s12014-017-9162-0
Full Text
Open PDFAbstract
Available in full text
Date
July 12, 2017
Authors
Publisher
Springer Science and Business Media LLC